Literature DB >> 28705461

Gonorrhoea vaccines: a step in the right direction.

Kate L Seib1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28705461     DOI: 10.1016/S0140-6736(17)31605-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  The growing epidemic of sexually transmitted infections in adolescents: a neglected population.

Authors:  Chelsea L Shannon; Jeffrey D Klausner
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

2.  Impact of meningococcal group B OMV vaccines, beyond their brief.

Authors:  Helen Petousis-Harris
Journal:  Hum Vaccin Immunother       Date:  2017-11-17       Impact factor: 3.452

3.  Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B.

Authors:  Irene Rivero-Calle; Peter Francis Raguindin; Jose Gómez-Rial; Carmen Rodriguez-Tenreiro; Federico Martinón-Torres
Journal:  Infect Drug Resist       Date:  2019-10-09       Impact factor: 4.003

4.  The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.

Authors:  Evgeny A Semchenko; Aimee Tan; Ray Borrow; Kate L Seib
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

5.  A dynamic power-law sexual network model of gonorrhoea outbreaks.

Authors:  Lilith K Whittles; Peter J White; Xavier Didelot
Journal:  PLoS Comput Biol       Date:  2019-03-08       Impact factor: 4.475

6.  A meningococcal B vaccine induces cross-protection against gonorrhea.

Authors:  Rolando Felipe Ochoa Azze
Journal:  Clin Exp Vaccine Res       Date:  2019-07-31

7.  Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics.

Authors:  Lilith K Whittles; Peter J White; Xavier Didelot
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.